Congenital adrenal hyperplasia||236.12 Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency||157.41 Endometrial hyperplasia||139.92 Lipoid congenital adrenal hyperplasia||139.92 Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency||131.18 Benign prostatic hyperplasia||131.18 Intersex surgery||96.2 Cellular adaptation||87.45 Congenital adrenal hyperplasia due to 3 beta-hydroxysteroid dehydrogenase deficiency||87.45 Gingival enlargement||69.96 Saw palmetto extract||61.21 Prostate||61.21 HSD3B2||52.47 Endometrial cancer||52.47 Steroid 11-beta-hydroxylase||52.47 Addison's disease||52.47 Endometrial intraepithelial neoplasia||52.47 Prostatic stent||43.72 Nodular regenerative hyperplasia||43.72 Prenatal hormones and sexual orientation||43.72 Inflammatory papillary hyperplasia||43.72 Serenoa||43.72 Pumpkin seed oil||43.72 International Prostate Symptom Score||43.72 Intimal hyperplasia||34.98 17-Hydroxypregnenolone||34.98 Virilization||34.98 5-alpha-reductase inhibitor||26.23 Steroidogenic acute regulatory protein||26.23 Alpha-1 adrenergic receptor||26.23 AFPep||26.23 Bartter syndrome||26.23 Transurethral microwave thermotherapy||26.23 Hematocrit||26.23 Liver tumor||26.23 17-Hydroxyprogesterone||26.23 Epulis fissuratum||26.23 Lower urinary tract symptoms||26.23 Frederic Bartter||26.23 Urinary retention||17.49 Adrenal insufficiency||17.49 Benign proliferative breast disease||17.49 Focal nodular hyperplasia||17.49 Silodosin||17.49 Fucoidan||17.49 Neuroendocrine hyperplasia||17.49 Rabson-Mendenhall syndrome||17.49 Atypical hyperplasia||17.49 Sebaceous hyperplasia||17.49